HDAC8 and hepatocellular carcinoma: HDAC8 can inhibit cell death mediated by p53/p21 and cell-cycle arrest at the G2/M phase and promote β-catenin-dependent cell proliferation by the interaction with chromatin modifier EZH2 to repress the Wnt antagonist in HCC (98).